Sigma is a search tool designed to allow you to quickly view the vast amount of information in the pharmaceutical landscape from the viewpoint that makes the most sense for you. We aggregate data from the full range of public domain resources and map relationships between investigators, diseases, drugs, sites, trials, MOAs, and industry news. Our clickable visual index allows industry experts to quickly view the data from a variety of different perspectives, or dig deeper into the results. Whether you work for brand marketing, a CRO, or a CI Team, Sigma enables to easily discover the information relevant to your needs.
Our human-assisted algorithms ensure we include the full range of rare diseases and orphan drugs in our database, allowing you to see the full spectrum of activity in a given therapeutic area.
View results by drug to determine level of advancement of a product, the level of clinical trial activity, and the level of investment from sponsors.
Search by MOA to quickly see the number of drugs in development and the diseases that the target applies to.
View key competitors and their pipelines. Find out which diseases and therapeutic areas they’re investing in, at what levels, and the status of current drug development.
Measure influence, recent publications, and view links to conference activity.
DRUG TRIALS
View all information on a trial, including enrollment dates, completion dates, primary and secondary endpoints, and patient populations.
Information in the public domain is often subject to variations in format that make easy comparison difficult. Our algorithms bring together disparate sources into a searchable database. As a result, a search in Sigma returns relevant results that other search tools (like Clinicaltrials.gov) might not. Key to each of the search features in Sigma are the construction of back-end ontologies that define disease, product and company association for each.
Sigma, unlike our flagship Delta platform, features a self-service model, perfect for ever-changing competitive intelligence or industry research needs. The interface is designed to be simple, but powerful.
Larvol Sigma’s search features allow you to cross-reference data and quickly navigate from one method of analysis to another, giving you a 360-degree view of the drug development landscape.
Sigma's visual results allow for easy interpretation of data at a glance, with different visuals to accompany different views. For example, Clinical Trials show progress via bars; the MOA view groups different drugs according to target.
Need to keep tabs on a particular topic? Sigma subscribers can set up Email Alerts to keep tabs on developments in clinical trials, or other news items related to a selected drug, investigator, MOA, or company.